CTNM
Contineum Therapeutics Inc.
$10.95
-$1.28(-10.43%)
75
Overall
60
Value
90
Tech
--
Quality
Market Cap
$340.56M
Volume
687.88K
52W Range
$3.35 - $16.25
Target Price
$22.67
EPS Estimates Overview
| Current Quarter | $-0.56 | Next Quarter | $-0.63 |
| Current Year | $-2.28 | Next Year | $-2.33 |
| QoQ Growth | -12.5% | YoY Growth | -2.2% |
| 3Y EPS CAGR | N/A | Target Price | $22.67 |
| Consensus | Buy | Upside | +107.1% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTNM | $10.95 | -10.4% | 687.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Contineum Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW